{"id":34960,"date":"2020-05-22T00:00:00","date_gmt":"2020-05-22T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2020\/05\/22\/u-s-offers-1-2-billion-to-drug-company-for-covid-19-vaccine-research\/"},"modified":"2020-05-26T16:10:05","modified_gmt":"2020-05-26T16:10:05","slug":"u-s-offers-1-2-billion-to-drug-company-for-covid-19-vaccine-research","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2020\/05\/22\/u-s-offers-1-2-billion-to-drug-company-for-covid-19-vaccine-research\/","title":{"rendered":"U.S. Offers &#36;1.2 Billion to Drug Company for COVID-19 Vaccine Research"},"content":{"rendered":"<h3>Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, May 22, 2020 (HealthDay News) &#8212; The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford, England.<\/p>\n<p>The fourth, and largest, vaccine research agreement funds a phase 3 clinical trial of the potential vaccine in the United States this summer with about 30,000 volunteers, <i>The New York Times<\/i> reported.<\/p>\n<p>The goal? To make at least 300 million doses that could be available as early as October, the HHS said in a statement. However, many experts have said that the earliest an effective, mass-produced vaccine would be available will not be until sometime next year, and billions of doses would be needed worldwide.<\/p>\n<p>The United States has already agreed to provide up to $483 million to the biotech company Moderna and $500 million to Johnson &#038; Johnson for their vaccine efforts. It is also providing $30 million to a virus vaccine effort led by the French company Sanofi, <i>The Times<\/i> reported.<\/p>\n<p><a href=\"https:\/\/www.nytimes.com\/2020\/05\/21\/health\/coronavirus-vaccine-astrazeneca.html\" target=\"_new\" rel=\"noopener noreferrer\"><i>The New York Times<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers<\/p>\n","protected":false},"author":6,"featured_media":35015,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-34960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/34960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=34960"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/34960\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/35015"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=34960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=34960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=34960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}